Dual blockade of CD47 and CD24 signaling using a novel bispecific antibody fusion protein enhances macrophage immunotherapy

CD47 and its receptor signal regulatory protein α (SIRPα) act as a dominant antiphagocytic, “don’t eat me” signal. Recent studies reveal CD24 as a novel target for cancer immunotherapy by macrophages in ovarian cancer and breast cancer. However, whether simultaneous blockade of CD47 and CD24 by a bi...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yun, Wu, He, Yang, Yan, Kang, Yan, He, Runjia, Zhou, Bei, Guo, Huaizu, Zhang, Jing, Li, Jianqin, Ge, Chunpo, Wang, Tianyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689933/
https://www.ncbi.nlm.nih.gov/pubmed/38046893
http://dx.doi.org/10.1016/j.omto.2023.100747

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689933/
https://www.ncbi.nlm.nih.gov/pubmed/38046893
http://dx.doi.org/10.1016/j.omto.2023.100747

Ejemplares similares